애질렉스 바이오랩스와 B2S 생명과학, 임상실험용 면역 분석법 바이오 분석에 대한 중요 주제 공유 Apr 29, 2021 08:00 HKT | ![Agilex](http://www.acnnewswire.com/images/toppage/agilex60.jpg) |
|
Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials Apr 29, 2021 04:00 HKT | ![Agilex](http://www.acnnewswire.com/images/toppage/agilex60.jpg) |
|
Agilex Biolabs收购领先的Biolab TetraQ作为APAC扩展计划的一部分 Apr 07, 2021 15:00 HKT | ![Agilex](http://www.acnnewswire.com/images/toppage/agilex60.jpg) |
|
Agilex Biolabs收購領先的Biolab TetraQ作為APAC擴展計劃的一部分 Apr 07, 2021 15:00 HKT | ![Agilex](http://www.acnnewswire.com/images/toppage/agilex60.jpg) |
|
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan Mar 24, 2021 05:00 HKT | ![TrialWire](http://www.acnnewswire.com/images/toppage/TrialWire45.jpg) |
|
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific Jan 28, 2021 07:00 HKT | ![APCO](http://www.acnnewswire.com/images/toppage/APCO64.jpg) |
|
Penanda aras baru yang akan memberikan penjagaan osteoporosis yang optimum ke seluruh Asia Pasifik Jan 28, 2021 01:30 HKT | ![APCO](http://www.acnnewswire.com/images/toppage/APCO64.jpg) |
|
최적의 골다공증 케어를 위한 새로운 아시아태평양 벤치마크 설정 Jan 28, 2021 01:30 HKT | ![APCO](http://www.acnnewswire.com/images/toppage/APCO64.jpg) |
|
新标准的设立将为整个亚太地区提供最佳的骨质疏松症医疗管理 Jan 28, 2021 01:30 HKT | ![APCO](http://www.acnnewswire.com/images/toppage/APCO64.jpg) |
|
New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific Jan 28, 2021 01:30 HKT | ![APCO](http://www.acnnewswire.com/images/toppage/APCO64.jpg) |
|
Azelis significantly increases its market presence in Vietnam through the acquisition of a majority shareholding in MKVN Chemicals and Viet Chemi Jan 05, 2021 14:35 HKT | ![Azelis](http://www.acnnewswire.com/images/toppage/Azelis_top.jpg) |
|
Sự hiện diện của Azelis trên thị trường Việt Nam đã được củng cố sâu sắc sau thương vụ thu mua đa số cổ phần tại MKVN Chemicals và Viet Chemi Jan 05, 2021 14:30 HKT | ![Azelis](http://www.acnnewswire.com/images/toppage/Azelis_top.jpg) |
|
AIM ImmunoTech宣布其药物Ampligen的ME/CFS临床试验已开始接受COVID-19长期患者的注册 Dec 24, 2020 21:00 HKT | ![AIM](http://www.acnnewswire.com/images/toppage/AIMImmunoTech1T.jpg) |
|
AIM ImmunoTech宣布其藥物Ampligen的ME/CFS臨床試驗已開始接受COVID-19長期患者的註冊 Dec 24, 2020 21:00 HKT | ![AIM](http://www.acnnewswire.com/images/toppage/AIMImmunoTech1T.jpg) |
|
Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002 Nov 12, 2020 15:00 HKT | |
|
Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020 Oct 28, 2020 00:03 HKT | ![Avance](http://www.acnnewswire.com/images/toppage/AvanceClinical25.jpg) |
|